Cost of hemophilia A in Turkey: an economic disease burden analysis
Makaleler > Tam Makale · 2021
Yazarlar: Simten Malhan, Ergun Oksuz, Bulent Antmen, Muhlis Cem Ar, Can BALKAN, Ramazan Kaan KAVAKLI
JOURNAL OF MEDICAL ECONOMICS, SCI Expanded İndekslerine Giren Dergi, Uluslararası, Scopus, 2021, cilt 24, ss 1052-1059
DOI: 10.1080/13696998.2021.1965388
Özet
Objective: Hemophilia A is the second most common bleeding disorder causing patients to have lifelong follow-up and treatment. Despite being a rare disease, hemophilia A has a high economic burden on individuals and the public. The purpose of this study was to estimate the total disease cost of hemophilia A in Turkey.